19-9810967-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017703.3(FBXL12):āc.910T>Gā(p.Cys304Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000707 in 1,613,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017703.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL12 | NM_017703.3 | c.910T>G | p.Cys304Gly | missense_variant | 3/3 | ENST00000247977.9 | NP_060173.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL12 | ENST00000247977.9 | c.910T>G | p.Cys304Gly | missense_variant | 3/3 | 1 | NM_017703.3 | ENSP00000247977 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152134Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000797 AC: 20AN: 250926Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135766
GnomAD4 exome AF: 0.0000712 AC: 104AN: 1460830Hom.: 0 Cov.: 30 AF XY: 0.0000647 AC XY: 47AN XY: 726490
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152252Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.910T>G (p.C304G) alteration is located in exon 3 (coding exon 3) of the FBXL12 gene. This alteration results from a T to G substitution at nucleotide position 910, causing the cysteine (C) at amino acid position 304 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at